Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $15.51 and last traded at $15.68, with a volume of 21611 shares changing hands. The stock had previously closed at $15.92.
Wall Street Analyst Weigh In
Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Read Our Latest Analysis on Avanos Medical
Avanos Medical Stock Performance
The company's fifty day moving average is $18.85 and its 200 day moving average is $21.16. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $716.01 million, a P/E ratio of 45.82 and a beta of 0.95.
Institutional Investors Weigh In On Avanos Medical
A number of institutional investors and hedge funds have recently bought and sold shares of AVNS. Quarry LP purchased a new position in shares of Avanos Medical during the third quarter worth approximately $42,000. KBC Group NV raised its position in Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock worth $68,000 after purchasing an additional 1,095 shares during the period. Canada Pension Plan Investment Board bought a new stake in Avanos Medical in the second quarter worth $70,000. XTX Topco Ltd purchased a new stake in Avanos Medical during the second quarter valued at about $202,000. Finally, Intech Investment Management LLC bought a new position in shares of Avanos Medical during the third quarter valued at about $207,000. 95.17% of the stock is owned by hedge funds and other institutional investors.
About Avanos Medical
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
